These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10563177)

  • 1. [Epidemiology of prostatic cancer].
    Harvei S
    Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3589-94. PubMed ID: 10563177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006.
    Bray F; Klint A; Gislum M; Hakulinen T; Engholm G; Tryggvadóttir L; Storm HH
    Acta Oncol; 2010 Jun; 49(5):644-54. PubMed ID: 20151937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.
    Kvåle R; Auvinen A; Adami HO; Klint A; Hernes E; Møller B; Pukkala E; Storm HH; Tryggvadottir L; Tretli S; Wahlqvist R; Weiderpass E; Bray F
    J Natl Cancer Inst; 2007 Dec; 99(24):1881-7. PubMed ID: 18073376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic cancer: some epidemiological features.
    Donn AS; Muir CS
    Bull Cancer; 1985; 72(5):381-90. PubMed ID: 3878166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of prostate cancer part I: descriptive epidemiology.
    Brawley OW; Knopf K; Merrill R
    Semin Urol Oncol; 1998 Nov; 16(4):187-92. PubMed ID: 9858324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era.
    Konety BR; Bird VY; Deorah S; Dahmoush L
    J Urol; 2005 Nov; 174(5):1785-8; discussion 1788. PubMed ID: 16217287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
    Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
    Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
    Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ
    J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer incidence and survival in relation to education (United States).
    Steenland K; Rodriguez C; Mondul A; Calle EE; Thun M
    Cancer Causes Control; 2004 Nov; 15(9):939-45. PubMed ID: 15577296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancers of the prostate, penis, and testicles: epidemiology, prevention, and treatment.
    Stotts RC
    Nurs Clin North Am; 2004 Jun; 39(2):327-40. PubMed ID: 15159183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam.
    Roobol MJ; Grenabo A; Schröder FH; Hugosson J
    J Natl Cancer Inst; 2007 Sep; 99(17):1296-303. PubMed ID: 17728218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival of patients with prostate cancer in northern Denmark, 1985-2004.
    Lund L; Jacobsen J; Borre M; Larsen EH; Graversen PH; Sørensen HT; Nørgaard M;
    Scand J Urol Nephrol; 2007; 41(4):308-13. PubMed ID: 17763222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer in Czech Republic 1959-1992. Descriptive survey.
    Celko AM
    Cent Eur J Public Health; 1995 Aug; 3(3):119-23. PubMed ID: 8535365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States.
    Jemal A; Ward E; Wu X; Martin HJ; McLaughlin CC; Thun MJ
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):590-5. PubMed ID: 15767335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis.
    Brenner H; Arndt V
    J Clin Oncol; 2005 Jan; 23(3):441-7. PubMed ID: 15572727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing demography of prostate cancer in Asia.
    Sim HG; Cheng CW
    Eur J Cancer; 2005 Apr; 41(6):834-45. PubMed ID: 15808953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostatic cancer in Oslo--a real decline?].
    Harvei S; Tretli S; Hagen S
    Tidsskr Nor Laegeforen; 1996 Feb; 116(6):750-4. PubMed ID: 8644080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
    Welch HG; Schwartz LM; Woloshin S
    J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.